We found that MIR155HG was significantly associated with immunological checkpoint blocking molecules PD‐1, PD‐L1, CTLA4, LAG3, and TIM3 in many tumors, and some of those types of tumor have better reactivity against immunological checkpoint blockade. The gene discussed is CTLA4; the disease is neoplasm.